3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
venetoclax
46
Azacitidine
35
Specimen Handling
34
Cytarabine
31
Biopsy
23
fludarabine
22
Cyclophosphamide
18
decitabine and cedazuridine drug combination
14
Injections
14
Daunorubicin
14
fludarabine phosphate
12
Whole-Body Irradiation
11
Busulfan
11
Mycophenolic Acid
10
Melphalan
10
Tacrolimus
9
Idarubicin
9
CPX-351
9
ivosidenib
8
Stem Cell Transplantation
8
Granulocyte Colony-Stimulating Factor
8
Gemtuzumab
7
Decitabine
7
Cyclosporine
7
enasidenib
6
X-Rays
6
Magnetic Resonance Spectroscopy
6
Filgrastim
6
gilteritinib
5
Sirolimus
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
2C4 antibody
×
30 days
×
Clear all
No trials found.